
Choosing a softgel contract manufacturer is one of the highest-stakes decisions a supplement brand makes. Softgels are among the most technically demanding dosage forms to produce: the shell formulation, fill chemistry, encapsulation conditions, and drying process all have to be controlled together, and mistakes show up months later as leaking capsules, cross-linked shells that will not dissolve, or failed stability tests. Unlike a tablet or powder, you cannot easily rework a bad softgel batch. This guide walks through the evaluation process the way an experienced sourcing manager would: what a softgel manufacturer actually needs to be good at, which certifications are meaningful, how to assess capacity and R&D depth, what to look for in quality systems, and the warning signs that should end a conversation early.
Why does your choice of softgel manufacturer matter more than for other dosage forms?
Because softgel production is unforgiving. A two-piece hard capsule can be filled on relatively simple equipment, and a tablet press operator can adjust compression in real time. Softgel encapsulation, by contrast, is a continuous process where gelatin ribbon thickness, die-roll alignment, fill weight, seam integrity, and tumble-drying conditions interact constantly. Small process drift produces defects that may not be visible at packout: shell brittleness in dry climates, capsule sticking in humid ones, or fill-shell interactions that degrade actives over shelf life.
The consequences of a weak manufacturing partner are also asymmetric. If your co-packer for powders makes an error, you typically lose a batch. If your softgel manufacturer ships product that fails dissolution or leaks in the bottle, you can lose a retail listing, face a recall, and spend a year rebuilding buyer trust. That is why sophisticated brands treat softgel supplier selection as a risk-management exercise, not a price-shopping exercise.
A few structural factors separate strong softgel manufacturers from weak ones:
- Shell formulation expertise. Gelatin sourcing and shell recipes must be matched to the fill. Plant-based HPMC shells require different equipment settings and know-how entirely.
- Environmental control. Encapsulation and drying rooms need tight humidity and temperature control; facilities that lack it produce seasonal quality swings.
- Analytical depth. In-house labs that can run identity, potency, dissolution, microbiological, and heavy-metal testing catch problems before product ships.
- Scale headroom. A partner running near full capacity will deprioritize your orders the moment a larger customer calls.
What certifications should a softgel contract manufacturer hold?
Certifications are the fastest way to filter a long supplier list down to a short one, because they represent third-party verification of quality systems you cannot fully audit yourself. For softgels sold as dietary supplements, look for the following tiers:
- GMP compliance for supplements — in the US context, conformity with 21 CFR Part 111. Third-party GMP certification such as NSF GMP (against the ANSI 455-2 standard) is stronger evidence than self-declared compliance, because it involves recurring on-site audits by an independent body.
- FDA facility registration — a baseline requirement for any factory shipping supplements into the United States. Note that registration is not approval; it simply means the facility is registered with FDA and subject to inspection.
- Food-safety system certifications — BRCGS, FSSC 22000, ISO 22000, and HACCP demonstrate that hazard analysis, traceability, and recall procedures are systematized. Major retailers and distributors increasingly require at least one GFSI-benchmarked scheme (BRCGS or FSSC 22000).
- Claim-supporting certifications — HALAL certification for Middle East and Southeast Asian markets, organic certification (such as EU organic) if you plan certified-organic SKUs, and kosher where relevant to your channel.
Zhongke Zhigu, for reference, operates under NSF GMP (ANSI 455-2), FDA facility registration, BRCGS, ISO 22000, HACCP, FSSC 22000, HALAL, and EU organic certification — you can review the full list and what each covers on our certifications page. Whichever supplier you evaluate, ask for current certificates with scope statements, and verify them with the issuing bodies. A dedicated breakdown of which certificates matter for which market is covered in our guide on certifications for buying softgels in bulk.
How do you assess a manufacturer's real production capacity?
Capacity claims are easy to make and hard to verify from a brochure, so probe for specifics. A credible softgel manufacturer should be able to tell you, without hesitation: how many encapsulation lines they run, their daily output in capsules (Zhongke Zhigu, for example, runs approximately 20 million softgels per day across gelatin and plant-based HPMC lines), what shell types and capsule sizes they support, and their current utilization rate. Vague answers on any of these points usually mean the numbers are aspirational.
Capacity matters for two practical reasons. First, headroom determines your lead times during peak season — a factory at 95 percent utilization cannot absorb your reorder surge in Q4. Second, scale correlates with process maturity: high-volume softgel plants have usually solved the humidity control, gelatin sourcing, and drying-tunnel problems that plague smaller operations.
Also examine breadth of dosage forms. If you expect your product line to expand beyond softgels — into gummies, tablets, hard capsules, powders, or liquids — a manufacturer that produces multiple dosage forms under one roof and one quality system simplifies your supply chain considerably. Consolidating with a single audited partner means one audit, one documentation standard, and one logistics flow instead of five. You can see how a multi-dosage-form facility is organized on our manufacturing page.
Finally, ask where key inputs come from. Manufacturers with in-house botanical extraction capability control identity and potency of plant-derived actives from raw herb onward, rather than relying entirely on third-party extract brokers — a meaningful advantage for botanical softgel lines.
What formulation and R&D support should you expect?
Unless you are handing over a fully validated formula, your manufacturer's R&D team will effectively co-develop your product, so evaluate them as you would a development partner. Strong softgel R&D groups can:
- Assess whether your desired actives are chemically compatible with a softgel fill (oil-soluble, suspension, or paste) and with the shell system you want;
- Reformulate for stability — adjusting antioxidants, carriers, and plasticizers to prevent oxidation, cross-linking, and leakage over shelf life;
- Advise on shell choice, including whether a gelatin or plant-based HPMC shell suits your market (a decision we unpack in our gelatin vs. HPMC guide);
- Run pilot batches and accelerated stability studies before you commit to commercial volumes;
- Support label and regulatory review for your destination markets.
Ask who leads the R&D function and how large the team is. Depth here varies enormously across the industry — at Zhongke Zhigu, R&D is led at academician level and connected to an in-house plant extraction workshop, which shortens the loop between raw material characterization and finished formulation. Whoever you choose, insist on seeing a development timeline in writing: how many weeks from brief to pilot batch, and what deliverables (spec sheet, stability protocol, CoA format) you receive at each stage.
How should you audit quality control and traceability?
Certificates tell you a quality system exists; an audit tells you whether it is lived. If you can visit the factory, spend your time in four places: incoming raw material quarantine, the encapsulation and drying rooms, the QC laboratory, and the documentation office. If you cannot visit, request the documents below and have a consultant review them:
- Certificates of Analysis for recent lots of a comparable product, showing identity, potency, dissolution or disintegration, microbiological limits, and heavy metals;
- A sample batch record (redacted is fine) demonstrating that critical process parameters are recorded and reviewed;
- Stability data for a softgel product in a similar fill matrix;
- The traceability procedure — how a finished lot links back to raw material lots, and how fast a mock recall can be executed.
Traceability deserves particular attention for softgels because the shell introduces supply-chain complexity that other dosage forms lack: gelatin origin (bovine, fish) carries religious, regulatory, and BSE-related documentation requirements, and plant-based shell polymers have their own sourcing chain. A manufacturer should be able to trace every component of a finished softgel — fill actives, carrier oils, shell polymer, colorants — to supplier lot level within hours, not days. Full-chain traceability is a core part of how we operate at Zhongke Zhigu; the system is described on our traceability page.
What questions should you ask before signing?
By the final round of evaluation, your questions should shift from capability to accountability. Put these on the table before any contract is drafted:
- Who owns the formula if the manufacturer develops or co-develops it — and is that stated in writing?
- What are the agreed specifications for release, and what happens (rework, replacement, credit) if a lot fails them?
- What are current MOQs, price breaks, and standard lead times for first orders versus reorders? (Industry norms are covered in our guide to softgel MOQs, pricing, and lead times.)
- How is your intellectual property protected — NDA scope, exclusivity options, and restrictions on selling your formula to others?
- What change-control notice will you receive if the manufacturer alters raw material suppliers, shell recipes, or processes?
- Which markets has the factory shipped to, and can they provide export documentation for yours?
- Who is your named point of contact after the sale, and what are response-time commitments?
Serious manufacturers answer these questions in specifics and put the answers in the quality agreement. Evasiveness at this stage predicts evasiveness when something goes wrong in production.
What red flags should make you walk away?
Some warning signs are worth treating as disqualifying no matter how attractive the price:
- No third-party GMP certification and reluctance to be audited. A factory confident in its systems welcomes scrutiny.
- Certificates that cannot be verified with the issuing body, are expired, or whose scope does not actually cover softgel manufacturing at that address.
- Prices dramatically below the market. Softgel economics are driven by raw materials and slow, controlled drying; a quote far under every competitor usually means corners cut on ingredient sourcing or testing.
- No in-house laboratory, with all testing outsourced and no ability to show raw data.
- Trading companies posing as factories. Ask for the manufacturing address on the certificates and match it to where your audit takes place. A broker in the middle adds cost and destroys traceability.
- Unwillingness to run a pilot batch or provide samples from your actual formula before commercial production.
- Vague answers on capacity and current utilization, which foreshadow missed ship dates.
None of these red flags is exotic; every experienced buyer has encountered them. The discipline is refusing to rationalize them because a quote looks good.
How do you run a low-risk first project with a new manufacturer?
Once you have a shortlisted partner, structure the first engagement to surface problems cheaply. Start with a paid sample and pilot run of your actual formula, not a stock product, so you see real development communication and real CoAs. Agree on the finished-product specification before pilot production, and test pilot samples at an independent laboratory in your own market. Place a first commercial order at or near the MOQ rather than committing to annual volumes, and track three things closely: whether documentation arrives complete and on time, whether the goods match the agreed spec on independent retest, and whether communication stays responsive after payment. A manufacturer that performs well under that scrutiny on a small order is one you can scale with confidence.
If you are evaluating suppliers for an upcoming softgel project, our team is glad to be part of that comparison. You can read how we structure softgel projects on our softgel contract manufacturing page, and when you are ready to discuss a specific formula, target market, and volumes, contact us — we will walk you through capabilities, certifications, and a realistic development timeline for your product.
Frequently asked questions
Should I visit the factory before signing a contract?
If the order value justifies the trip, yes — an on-site audit reveals things documents cannot, such as housekeeping, humidity control, and how staff actually handle materials. If travel is impractical, commission a third-party audit firm in-country or request a live video walkthrough plus the full document package. Never rely on marketing photos alone.
How long does it take to onboard a new softgel manufacturer?
For a custom formula, plan on roughly three to six months from first contact to first commercial shipment: supplier qualification and NDA, formulation and pilot batches, stability and specification agreement, then the first production slot. Stock or lightly modified formulas can move meaningfully faster.
Who owns the formula when a contract manufacturer develops it?
It depends entirely on the agreement, which is why you must settle it in writing before development starts. Common arrangements include full ownership transferring to the brand after development fees are paid, or the manufacturer retaining the base formula with exclusivity granted to the brand. Ask directly and get the answer into the contract.
What is the difference between private label and custom manufacturing?
Private label means putting your brand on a manufacturer's existing stock formula — faster and cheaper, with lower MOQs, but with no exclusivity. Custom contract manufacturing means producing your own formula to your specification — slower to launch and higher MOQ, but differentiated and controllable. Many brands start private label and migrate hero SKUs to custom formulas.
Do overseas manufacturers sign NDAs, and are they enforceable?
Reputable Chinese manufacturers routinely sign NDAs, and enforceability improves substantially if you use an agreement drafted for Chinese jurisdiction (often called an NNN agreement covering non-disclosure, non-use, and non-circumvention) rather than a US-style NDA. Have it reviewed by counsel familiar with China supply contracts.
Can one manufacturer handle both my softgels and other dosage forms?
Some can — larger facilities produce softgels alongside hard capsules, gummies, tablets, powders, and liquids under one quality system. Consolidating reduces audit burden and freight complexity, but confirm each dosage form is a genuine in-house capability rather than subcontracted, since subcontracting reintroduces the traceability risk you consolidated to avoid.